Explore the Site
Home
Latest News
AusBiotech
Events
About
Contact
Subscribe
Search
Follow Us
LinkedIn
Twitter
Instagram
BiotechDispatch
Menu
March 15, 2026
Subscribe
Login
Home
Latest News
AusBiotech
Events
About
Contact
Subscribe
Search
Sign In
Login
Forgot password?
Contact Us
Suite 9214
4 Duff Place
Deakin
ACT
2600
t. 0408 492 937
e.
contact@dailydispatch.com.au
Most Read
A new prostate cancer technology moves closer to global trials after strong early results
March 12, 2026 - Latest News
Cell therapy company Mesoblast names executive to guide clinical development and medical affairs
March 12, 2026 - Latest News
Imugene launches $20 million capital raise to fund expansion of Azer Cel trials
March 12, 2026 - Latest News
Patrys moves toward first human trial for injectable delirium therapy
March 12, 2026 - Latest News
Follow Us
LinkedIn
Twitter
Instagram
New Stories
A new prostate cancer technology moves closer to global trials after strong early results
March 12, 2026 - - Latest News
Cell therapy company Mesoblast names executive to guide clinical development and medical affairs
March 12, 2026 - - Latest News
Patrys moves toward first human trial for injectable delirium therapy
March 12, 2026 - - Latest News
Imugene launches $20 million capital raise to fund expansion of Azer Cel trials
March 12, 2026 - - Latest News
CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production
March 10, 2026 - - Latest News
Telix Phase 3 cancer study shows encouraging safety results for novel radiotherapy
March 10, 2026 -
Imugene reports strong early results in Azer-Cel cancer clinical trial
March 10, 2026 - - Latest News